SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-24-157358
Filing Date
2024-06-07
Accepted
2024-06-07 16:14:07
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B4 d803738d424b4.htm 424B4 2570626
2 GRAPHIC g803738g00m02.jpg GRAPHIC 41235
3 GRAPHIC g803738g00m26.jpg GRAPHIC 131536
4 GRAPHIC g803738g00m27.jpg GRAPHIC 137274
5 GRAPHIC g803738g00m29.jpg GRAPHIC 96411
6 GRAPHIC g803738g00m30.jpg GRAPHIC 110968
7 GRAPHIC g803738g00m31.jpg GRAPHIC 107683
8 GRAPHIC g803738g00m33.jpg GRAPHIC 114611
9 GRAPHIC g803738g25c41.jpg GRAPHIC 200531
10 GRAPHIC g803738g35h11.jpg GRAPHIC 144342
11 GRAPHIC g803738g41i38.jpg GRAPHIC 80014
12 GRAPHIC g803738g56a01.jpg GRAPHIC 81756
13 GRAPHIC g803738g76c15.jpg GRAPHIC 81101
14 GRAPHIC g803738g91o98.jpg GRAPHIC 124443
  Complete submission text file 0001193125-24-157358.txt   4530313
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

IRS No.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-279486 | Film No.: 241029553
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)